The study team will assess the efficacy of platelet-rich plasma therapy, a special blood product which is from the participant's own body, in the treatment of androgenic alopecia (also known as male pattern hair loss) in females.
Female ≥18 years of age at baseline visit.
Documentation of androgenic alopecia diagnosis as evidenced by one or more clinical features
Not currently on any treatment for alopecia, or has undergone 2-week washout period if recently on medication(s) for alopecia
Written informed consent obtained from subject and ability for subject to comply with the requirements of the study
Pregnant or breastfeeding
Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.
Have an infection, metastatic disease or certain skin conditions (ie. Psoriasis) which could worsen or spread with injections
Diagnosed with a blood or bleeding disorder